Adam Feuerstein

Senior Writer
Before joining TheStreet.com in March 2001, Feuerstein covered business software for Upside.com. Prior to that he covered a variety of business beats, including technology and commercial real estate, at the San Francisco Business Times.

Feuerstein graduated from Emory University with a bachelor's degree in political science.

By This Author:
« Back
Page 1 of 2
Video

Biotech Is Back, But Don't Get Burned

By Gregg Greenberg | By Adam Feuerstein

Risk has returned to the market, and it's benefiting biotech stocks. Adam Feuerstein, senior writer at TheStreet.com, says the ones to watch are Vertex and BioMarin.

Related Topics: Biotech

06:41PM 04/07/08

Video

Biotech Investors are Playing It Safe

By Adam Feuerstein

TheStreet.com's biotech specialist, Adam Feuerstein, gives the highlights from the BioCEO Conference and explains why biotech investors may want to stick with ETFs for a while.

10:43AM 02/20/08

Video

Biotech Investors Playing It Safe

By Adam Feuerstein | By Gregg Greenberg

TheStreet.com's biotech specialist, Adam Feuerstein, gives the highlights from the BioCEO Conference and explains why biotech investors may want to stick with ETFs for a while.

Related Topics: Biotech

11:35AM 02/14/08

Video

Biotech Buzz: Big Strides in Alzheimer's Drugs

By Adam Feuerstein

Adam Feuerstein wraps up a week at the JPMorgan Healthcare Conference.

05:46PM 01/10/08

Video

The Cancer Drug to Watch in 2008

By Adam Feuerstein

Onyx Pharma's CEO gives his take on what's in store for 2008, and why a Nexavar lung cancer trial will be the big stock-moving event this year.

Related Topics: Biotech

02:38PM 01/08/08

Video

Biotech Buzz: Fresh News From JP Morgan Confab

By Adam Feuerstein

Adam Feuerstein delivers the buzz-worthy biotech news from Day One of the confab.

Related Topics: Biotech

12:09PM 01/08/08

Video

These Hematology Stocks Are Bloody Good

By Adam Feuerstein

From Seattle Genetics to Celgene, hear what hematology drug stocks could move ahead of the annual American Society of Hematology Conference.

06:59AM 11/12/07

Video

Biotech Guru Digs Into Vertex, Other Hep-C Stocks

By Adam Feuerstein

TheStreet.com's biotech guru, Adam Feuerstein, analyzes Vertex and other drug firms working on new treatments for hepatitis C.

04:46PM 11/09/07

Video

Feuerstein's Biotech Insights: ONXX NSTK

By Adam Feuerstein | By Aaron Task

TheStreet.com's Adam Feuerstein analyses today's big biotech movers.

04:16PM 11/07/07

Video

Cramer: Avoid Amgen

By Adam Feuerstein | By Jim Cramer

Despite some positive news, Adam Feuerstein tells Jim Cramer why everyone should avoid this biotech play.

06:45AM 09/30/07

« Back
Page 1 of 2
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Premium Stock Ideas